{
  "source_document": "9-Combined_metabolomic_and_metagenomic_analysis.pdf",
  "test_cases": [
{
  "id": "ibd_metabolomics_001",
  "query": "What age ranges were used for pediatric and adult patient groups in this IBD study?",
  "ground_truth_answer": "Pediatric patients ranged from 5 to 15 years old, while adult patients ranged from 45 to 70 years old. All samples were collected during disease exacerbation between September 2024 to December 2024.",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "easy",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_002",
  "query": "What sequencing platform was used for 16S rRNA gene sequencing in this study?",
  "ground_truth_answer": "The MinION™ Mk1B platform (Oxford Nanopore Technologies) was used for 16S rRNA gene sequencing, with data acquisition carried out via MinKNOW software version 22.12.7",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "easy",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_003",
  "query": "What analytical instrument was used for metabolomic profiling of stool samples?",
  "ground_truth_answer": "Stool samples were analyzed using a Shimadzu QP2010 Ultra GC/MS system equipped with a Shimadzu HS-20 headspace extractor. The system used a VF-WAXMS column with helium as the carrier gas.",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "easy",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_004",
  "query": "How many bacterial species were identified in pediatric versus adult IBD patient samples?",
  "ground_truth_answer": "Sequencing identified 554 microbial species belonging to 224 total genera in 71 pediatric patient samples, and 654 microbial species belonging to 267 total genera in 36 adult patient samples",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "easy",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_005",
  "query": "What percentage of volatile compounds detected were used for metabolomic profile comparison?",
  "ground_truth_answer": "A minimum of 60% of the stable compounds identified were utilized for metabolomic profile comparison. The most frequently observed compounds meeting the screening criteria included SCFAs, medium- and long-chain fatty acids, and amino acid derivatives",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "easy",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_006",
  "query": "How did Shannon diversity index differ between pediatric and adult IBD patients, and what does this indicate?",
  "ground_truth_answer": "Shannon's alpha diversity index was significantly lower in children compared to adults across both control groups and groups with colitis and CD. This reduced bacterial diversity was observed in children across all experimental conditions, indicating age-related differences in microbiome complexity. During disease development, the microbiomes of children and adults undergo similar changes, but children start with lower baseline diversity",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "mechanism"
},
{
  "id": "ibd_metabolomics_007",
  "query": "Explain the role of indole metabolites in IBD according to the study findings",
  "ground_truth_answer": "Indole levels were significantly reduced across the entire IBD group including both CD and UC patients. This decrease indicates a diminished presence of bacteria actively producing and secreting indole, reflecting microbiota alterations. The gut microbiome plays a crucial role in tryptophan metabolism, producing various indole derivatives that influence the host's immune response and intestinal health. 1H-indole-3-methyl (skatole) can enhance promoter activity of cytokines such as IL-6 and TNF-α, significantly influencing IBD development and progression",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "mechanism"
},
{
  "id": "ibd_metabolomics_008",
  "query": "What metabolic differences distinguish UC from CD in pediatric patients?",
  "ground_truth_answer": "UC exhibits characteristic changes in pentanoic acid, 4-methylphenol (p-cresol), and acetate levels, while CD is characterized by elevated tetradecanoic acid and reduced 1H-indole-3-methyl. The UC risk prediction model incorporates three metabolic biomarkers: elevated risk coefficient score, increased acetate levels, decreased pentanoic acid, and altered excretion of p-cresol. The CD risk stratification model identifies high-risk patients based on elevated IBD risk coefficient score and reduced levels of 1H-indole-3-methyl",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "comparison"
},
{
  "id": "ibd_metabolomics_009",
  "query": "How do SCFAs relate to IBD pathology according to the correlation analysis?",
  "ground_truth_answer": "There is considerable variability in Shannon diversity index for SCFAs in UC compared to CD. In pediatric CD, butyrate and propionate derivatives increase in tandem with changes in bacteria such as Prevotella copri and Bifidobacterium adolescentis. Significant amounts of Blautia bacteria positively correlate with levels of various propionate derivatives. Alterations in gut microbiota composition and decreased fermentation of dietary fibers in IBD lead to changes in SCFAs. SCFAs play crucial roles in regulating immune responses and promoting tissue repair within the gut",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "mechanism"
},
{
  "id": "ibd_metabolomics_010",
  "query": "What is the significance of Streptococcus salivarius as a biomarker in pediatric IBD?",
  "ground_truth_answer": "Streptococcus salivarius appears to be a universal metagenomic marker for IBD development in the pediatric group (log2FoldChange = 3.31, FDR < 0.0001). It shows significant increase in certain Streptococcus species in patients with UC. The content of Streptococcus salivarius is inversely proportional to the level of heptanoic acid. Some studies suggest it may have anti-inflammatory properties and can modulate immune responses, including inhibiting the nuclear factor-kappaB pathway in human intestinal epithelial cells. However, its abundance is increased in UC patients, showing inverse correlation with heptanoic acid",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "mechanism"
},
{
  "id": "ibd_metabolomics_011",
  "query": "Describe the functional metabolomics approach used in this study and its advantages",
  "ground_truth_answer": "Functional metabolomics combines the ability to simultaneously assess microbiome diversity and evaluate its secretory activity in pathology development. The study used HS-GC-MS (headspace-gas chromatography-mass spectrometry) for VOC profiling, which enables comparison of various biological samples including feces, since ratios of components in equilibrium vapor don't depend on water content. This approach analyzes SCFAs, medium-chain and long-chain fatty acids, acids with phenyl radicals, aldehydes, and heterocycles. The vapor-phase extraction method makes it possible to compare samples with different water content and provides insights into microbial metabolic activity",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "mechanism"
},
{
  "id": "ibd_metabolomics_012",
  "query": "Compare the metagenomic signatures of CD between pediatric and adult patients, and explain what this reveals about disease pathogenesis",
  "ground_truth_answer": "Pediatric CD patients showed significant increases in Ralstonia insidiosa, Stenotrophomonas maltophilia, and Erysipelatoclostridium ramosum, while showing decreases in Blautia spp. and Coprococcus comes. However, the expected increase in Escherichia coli was not observed in adult CD patients, despite being elevated in pediatric CD (log2FoldChange = 3.45, FDR = 0.007). Pediatric patients had a more consolidated metabolome spectrum than adults, with more homogeneous metabolomic profiles, suggesting a special mechanism of CD development in childhood. The metabolome differences between adults and children may reflect that pediatric CD represents primary alterations, while adult CD may be caused by both endogenous and exogenous factors that dramatically change microbiota. This distinction suggests CD in children has more limited spectrum of metabolic and metagenomic changes, which may enhance prospects for identifying specific pathognomonic factors",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "hard",
  "category": "comparison"
},
{
  "id": "ibd_metabolomics_013",
  "query": "Explain the diagnostic algorithm developed for pediatric IBD risk assessment, including the mathematical basis and clinical interpretation thresholds",
  "ground_truth_answer": "The risk coefficient formula includes metabolites that are significantly different between IBD and control groups. For statistically significant metabolites, biserial correlation was calculated with FDR correction; metabolites with absolute correlation coefficient |r| > 0.3 were included. Positively correlated metabolites were placed in the numerator, negatively correlated ones in the denominator: Kr = log₁₀(1/(pentanoic acid + Phenol,4-methyl + Indole)). ROC analysis determined risk thresholds: values below the 5th percentile indicated no risk (Kr < 4.01), values between 4.01 and 4.79 suggest low risk requiring additional clinical markers, and values above 4.79 (above 25th percentile) indicate high risk requiring further examination and can detect asymptomatic cases. For differential diagnosis, high-risk CD cases show reduced 1H-indole-3-methyl, while UC cases show altered pentanoic acid, phenol 4-methyl, and acetate levels",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "hard",
  "category": "mechanism"
},
{
  "id": "ibd_metabolomics_014",
  "query": "Analyze the paradoxical finding that pediatric IBD patients showed greater metabolite diversity than controls, contrary to expectations. What mechanisms might explain this?",
  "ground_truth_answer": "Contrary to initial expectations, comprehensive metabolomic profiling revealed that the control group had fewer diversely represented volatile metabolites than the IBD group in pediatric patients (opposite to adult patterns). This paradoxical finding may be explained by several factors: (1) therapy being taken by patients may introduce additional metabolites, (2) excessive bacterial growth in IBD provokes secretion of numerous volatile components, (3) treatment-derived xenobiotic metabolites significantly contribute to observed metabolic signatures. While patients with IBD typically have reduced microbiota diversity (which should result in fewer identified metabolites), the overall spectrum of detectable metabolites is actually larger due to these additional factors. In contrast, adults with chronic IBD demonstrate a more stable metabolomic profile reflecting long-term adaptation to disease. This suggests the wide variety of components in pediatric IBD patients reflects acute dysbiosis and therapeutic intervention rather than adaptive microbiome changes",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "hard",
  "category": "mechanism"
}
  ],
    "mcq_questions": [
{
  "id": "ibd_metabolomics_015",
  "query": "Discuss the clinical implications of the five microbial signatures identified for CD diagnosis and their potential pathogenic mechanisms",
  "ground_truth_answer": "The five microbial signatures with diagnostic potential for CD are: (1) Ralstonia insidiosa - an opportunistic pathogen typically found in hospital settings; while not directly implicated in IBD causation, both R. insidiosa and CD patients share vulnerability to opportunistic infections due to compromised immune systems; (2) Stenotrophomonas maltophilia - an opportunistic pathogen resistant to many antibiotics that can worsen IBD symptoms, potentially leading to increased inflammation and malabsorption; (3) Erysipelatoclostridium ramosum - detected in fecal and biopsy samples from IBD patients, produces an enzyme degrading immunoglobulin A (crucial mucosal antibody), impairing immune system's ability to combat pathogens and potentially worsening inflammation; (4) Blautia spp. (decreased) - produces SCFAs beneficial for gut health, can modulate immune responses, and specific strains alleviate colitis in animal models by reducing inflammation and enhancing gut barrier integrity; (5) Coprococcus comes (decreased) - produces SCFAs (primarily acetate) with anti-inflammatory properties, helps restore gut barrier integrity by enhancing goblet cell maturation. The decrease in beneficial bacteria (Blautia, Coprococcus) combined with increase in opportunistic pathogens represents a specific dysbiotic signature distinguishing CD from UC and controls",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "hard",
  "category": "mechanism"
},
{
  "id": "ibd_metabolomics_mcq_001",
  "question": "What was the total size of the study cohort including all groups?",
  "options": [
    "A) 100 participants (34 adults, 66 pediatric)",
    "B) 149 participants (34 adult IBD, 66 pediatric IBD, 49 healthy controls)",
    "C) 115 participants (49 adults, 66 pediatric)",
    "D) 183 participants (66 adults, 66 pediatric, 51 controls)"
  ],
  "correct_answer": "B",
  "explanation": "The study included an adult IBD group (n = 34), a pediatric IBD group (n = 66), and a healthy control group comprising both adults and children (n = 49), for a total of 149 participants",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "easy",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_mcq_002",
  "question": "Which analytical software was used for mass spectral deconvolution and identification?",
  "options": [
    "A) MassHunter version 2.0",
    "B) AMDIS (Automated Mass Spectral Deconvolution and Identification System) version 2.72",
    "C) Xcalibur software version 4.1",
    "D) OpenChrom version 1.5"
  ],
  "correct_answer": "B",
  "explanation": "The study used AMDIS (Automated Mass Spectral Deconvolution and Identification System) version 2.72 in conjunction with the National Institute of Standards and Technology 2014 mass spectra library to analyze the obtained mass spectra",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "easy",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_mcq_003",
  "question": "What primers were used for 16S rRNA gene amplification in this study?",
  "options": [
    "A) 515F and 806R",
    "B) 27F (AGAGTTTGATYMTGGCTCAG) and 1492R (GGTTACCTTGTTAYGACTT)",
    "C) 341F and 785R",
    "D) 8F and 1541R"
  ],
  "correct_answer": "B",
  "explanation": "The study used primers 27F (AGAGTTTGATYMTGGCTCAG) and 1492R (GGTTACCTTGTTAYGACTT) to amplify the 16S rRNA gene, with the PCR carried out using Tersus Plus PCR Kit",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "easy",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_mcq_004",
  "question": "Which bacterial phylum showed significant depletion across all IBD groups compared to controls?",
  "options": [
    "A) Bacteroidota",
    "B) Proteobacteria",
    "C) Firmicutes",
    "D) Actinobacteria"
  ],
  "correct_answer": "C",
  "explanation": "Quantitative microbiome analysis demonstrated consistent Firmicutes depletion across all IBD groups. The study noted significant reductions in Actinobacteria and Firmicutes phyla with 19 species of beneficial Bifidobacterium decreased in IBD patients",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_mcq_005",
  "question": "What was the key finding regarding Bacteroidota abundance in pediatric vs adult IBD patients?",
  "options": [
    "A) Pediatric patients showed higher Bacteroidota than adults",
    "B) Pediatric IBD patients showed lower Bacteroidota prevalence compared to adults",
    "C) No significant difference was observed",
    "D) Bacteroidota was absent in pediatric patients"
  ],
  "correct_answer": "B",
  "explanation": "Comparative analysis revealed significant age-related differences in the abundance of Bacteroidota, with pediatric IBD patients showing a lower prevalence compared to adults. Significant Bacteroidetes depletion was particularly noted in the UC group",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "comparison"
},
{
  "id": "ibd_metabolomics_mcq_006",
  "question": "Which metabolite showed an inverse correlation with Escherichia coli abundance in pediatric CD patients?",
  "options": [
    "A) Acetic acid",
    "B) Benzoic acid",
    "C) Propionic acid",
    "D) Butyric acid"
  ],
  "correct_answer": "B",
  "explanation": "The study found that Escherichia coli, a well-known risk factor associated with CD, shows an inverse correlation with benzoic acid levels in pediatric CD patients",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "mechanism"
},
{
  "id": "ibd_metabolomics_mcq_007",
  "question": "What statistical method was used to identify differentially abundant microbial species?",
  "options": [
    "A) DESeq2 with Wald test",
    "B) Maaslin2 v.1.22.0 with thresholds: minimum abundance = 0.01, minimum prevalence = 0.25, max significance (FDR) = 0.05",
    "C) EdgeR with likelihood ratio test",
    "D) ANCOM-BC with bias correction"
  ],
  "correct_answer": "B",
  "explanation": "To identify taxa with statistically significant differences in representation between comparison groups, the Maaslin2 v.1.22.0 tool was utilized with specific thresholds: minimum abundance = 0.01, minimum prevalence = 0.25, max significance (false discovery rate) = 0.05, along with LEfSe v.1.1.2",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_mcq_008",
  "question": "How did the study handle missing values in the metabolomic data?",
  "options": [
    "A) Complete case analysis (deletion of samples with missing data)",
    "B) Mean imputation",
    "C) Bayesian PCA (BPCA) approach after confirming data met MAR assumption using χ² test",
    "D) Multiple imputation by chained equations (MICE)"
  ],
  "correct_answer": "C",
  "explanation": "A χ²d test guided the choice of imputation method for missing values, revealing that the data met the missing at random (MAR) assumption. Based on this, the Bayesian principal component analysis (BPCA) approach was selected as the optimal imputation technique",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "medium",
  "category": "mechanism"
},
{
  "id": "ibd_metabolomics_mcq_009",
  "question": "Which combination of genera showed significant enrichment specifically in the UC pediatric group?",
  "options": [
    "A) Bacteroides and Prevotella",
    "B) Enterococcus and Lactobacillus",
    "C) Faecalibacterium and Roseburia",
    "D) Escherichia and Klebsiella"
  ],
  "correct_answer": "B",
  "explanation": "Significant enrichment of Enterococcus and Lactobacillus representatives was observed in the UC group. The study notes that Enterococcus and Lactobacillus increased possibly as a result of taking a probiotic, distinguishing the UC phenotype from CD",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "hard",
  "category": "factual"
},
{
  "id": "ibd_metabolomics_mcq_010",
  "question": "What was the key mechanistic finding regarding Akkermansia in IBD patients?",
  "options": [
    "A) Akkermansia increased in both UC and CD, promoting inflammation",
    "B) Akkermansia showed no significant change across any IBD subtype",
    "C) Akkermansia significantly decreased in both UC and CD patients; it has ability to restrain autoimmune reactions and reduce proinflammatory cytokines",
    "D) Akkermansia increased only in CD but decreased in UC"
  ],
  "correct_answer": "C",
  "explanation": "An important feature identified was a significant decrease in representatives of the genus Akkermansia in patients with both UC and CD. It is known that Akkermansia spp. have the ability to restrain autoimmune reactions and reduce proinflammatory cytokines, making its depletion significant for IBD pathogenesis",
  "expected_documents": [
    "9-Combined_metabolomic_and_metagenomic_analysis.pdf"
  ],
  "difficulty": "hard",
  "category": "mechanism"
}
  ]
}